• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

袖状胃切除术作为一种独立的减肥手术,用于治疗重度、病态和超级肥胖症。

Sleeve gastrectomy as a stand-alone bariatric operation for severe, morbid, and super obesity.

作者信息

Eisenberg Dan, Bellatorre Anna, Bellatorre Nina

机构信息

Department of Surgery, Stanford School of Medicine, Stanford, CA, USA.

出版信息

JSLS. 2013 Jan-Mar;17(1):63-7. doi: 10.4293/108680812X13517013317077.

DOI:10.4293/108680812X13517013317077
PMID:23743373
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3662747/
Abstract

BACKGROUND

The laparoscopic sleeve gastrectomy (LSG) is emerging as an effective bariatric operation and is especially attractive in high-risk populations. In this study we examine the efficacy of LSG as a stand-alone operation in the veteran population.

METHODS

This is a retrospective review of consecutive patients who underwent LSG as a stand-alone procedure at the Palo Alto Veterans Affairs medical center with a minimum 12-month follow-up.

RESULTS

Of 205 patients undergoing bariatric surgery, 71 patients had a sleeve gastrectomy, 40 of whom had the operation performed at least 12 months previously. Thirty-six (90%) were available for 1-year follow-up, with a mean follow-up duration of 22 months (range: 12-42), a mean body mass index of 48.3 kg/m(2), and an 83% male population. Mean percent excess weight loss was 61% at an average of 22 months, with no significant difference between severely obese, morbidly obese, and super obese cohorts. Diabetes remission was seen in 56% of patients, hypertension remission in 51.6%, and obstructive sleep apnea remission in 46.4%, and gastroesophageal reflux disease improved or did not change in 83%. Medication use significantly decreased after surgery.

CONCLUSION

LSG is safe and effective as a stand-alone bariatric operation in the high-risk veteran population. It is effective in severely obese, morbidly obese, and super obese patients. LSG induces remission or improvement in comorbidities of nearly all patients, translating to a decrease in medication use.

摘要

背景

腹腔镜袖状胃切除术(LSG)正逐渐成为一种有效的减肥手术,在高危人群中尤其具有吸引力。在本研究中,我们探讨了LSG作为一种独立手术在退伍军人中的疗效。

方法

这是一项对在帕洛阿尔托退伍军人事务医疗中心接受LSG独立手术且至少随访12个月的连续患者的回顾性研究。

结果

在205例行减肥手术的患者中,71例接受了袖状胃切除术,其中40例手术至少在12个月前进行。36例(90%)患者可进行1年随访,平均随访时间为22个月(范围:12 - 42个月),平均体重指数为48.3 kg/m²,男性占83%。平均超重减轻百分比在平均22个月时为61%,重度肥胖、病态肥胖和超级肥胖队列之间无显著差异。56%的患者糖尿病缓解,51.6%的患者高血压缓解,46.4%的患者阻塞性睡眠呼吸暂停缓解,83%的胃食管反流病患者病情改善或未改变。术后药物使用显著减少。

结论

LSG作为一种独立的减肥手术在高危退伍军人人群中是安全有效的。它对重度肥胖、病态肥胖和超级肥胖患者均有效。LSG可使几乎所有患者的合并症缓解或改善,从而减少药物使用。

相似文献

1
Sleeve gastrectomy as a stand-alone bariatric operation for severe, morbid, and super obesity.袖状胃切除术作为一种独立的减肥手术,用于治疗重度、病态和超级肥胖症。
JSLS. 2013 Jan-Mar;17(1):63-7. doi: 10.4293/108680812X13517013317077.
2
Midterm outcomes of laparoscopic sleeve gastrectomy as a stand-alone procedure in super-obese patients.腹腔镜袖状胃切除术作为一种独立术式在超级肥胖患者中的中期结果。
Surg Obes Relat Dis. 2018 Mar;14(3):297-303. doi: 10.1016/j.soard.2017.11.021. Epub 2017 Nov 22.
3
Comparative Effectiveness of Laparoscopic Sleeve Gastrectomy on Morbidly Obese, Super-Obese, and Super-Super Obese Patients for the Treatment of Morbid Obesity.腹腔镜袖状胃切除术治疗病态肥胖、超病态肥胖和超级超病态肥胖患者的疗效比较。
Obes Surg. 2018 Jun;28(6):1484-1491. doi: 10.1007/s11695-017-3053-3.
4
Outcomes of Laparoscopic Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in Patients Older than 60.60岁以上患者行腹腔镜袖状胃切除术和Roux-en-Y胃旁路术的疗效
Obes Surg. 2015 Dec;25(12):2251-6. doi: 10.1007/s11695-015-1712-9.
5
Safety and short-term outcomes of laparoscopic sleeve gastrectomy for patients over 65 years old with severe obesity.腹腔镜袖状胃切除术治疗 65 岁以上肥胖症患者的安全性和短期疗效。
Surg Obes Relat Dis. 2018 Jul;14(7):952-959. doi: 10.1016/j.soard.2018.03.002. Epub 2018 Mar 8.
6
Laparoscopic sleeve gastrectomy in the South Pacific. Retrospective evaluation of 510 patients in a single institution.腹腔镜袖状胃切除术在南太平洋地区的应用。单中心 510 例患者的回顾性评估。
Int J Surg. 2016 Jun;30:1-6. doi: 10.1016/j.ijsu.2016.04.002. Epub 2016 Apr 8.
7
Mid-term bariatric surgery outcomes for obese patients: does weight matter?肥胖患者的中期减肥手术结果:体重有影响吗?
Ann R Coll Surg Engl. 2020 Jan;102(1):54-61. doi: 10.1308/rcsann.2019.0100. Epub 2019 Sep 6.
8
Laparoscopic Sleeve Gastrectomy for Morbid Obesity at a Veterans Affairs Medical Center.退伍军人事务医疗中心的腹腔镜袖状胃切除术治疗病态肥胖症
J Laparoendosc Adv Surg Tech A. 2018 Jun;28(6):650-655. doi: 10.1089/lap.2018.0002. Epub 2018 Mar 28.
9
Trending Weight Loss Patterns in Obese and Super Obese Adolescents: Does Laparoscopic Sleeve Gastrectomy Provide Equivalent Outcomes in both Groups?肥胖和超级肥胖青少年的流行减肥模式:腹腔镜袖状胃切除术在两组中是否能提供相同的结果?
Obes Surg. 2019 Aug;29(8):2511-2516. doi: 10.1007/s11695-019-03867-8.
10
Laparoscopic Sleeve Gastrectomy: Endoscopic Findings and Gastroesophageal Reflux Symptoms at 18-Month Follow-Up.腹腔镜袖状胃切除术:18个月随访时的内镜检查结果及胃食管反流症状
J Laparoendosc Adv Surg Tech A. 2018 Jan;28(1):71-77. doi: 10.1089/lap.2017.0398. Epub 2017 Dec 11.

引用本文的文献

1
Bariatric Surgery in Obesity: Metabolic Quality Analysis and Comparison of Surgical Options.肥胖症的减重手术:代谢质量分析及手术方案比较。
Adv Exp Med Biol. 2024;1460:697-726. doi: 10.1007/978-3-031-63657-8_24.
2
Laparoscopic Sleeve Gastrectomy as a First Step Procedure for Oncologic Purposes: An Indication Beyond the Updated Guidelines.腹腔镜袖状胃切除术作为一种针对肿瘤目的的第一步手术:超越最新指南的适应证。
Obes Surg. 2024 Jun;34(6):2026-2032. doi: 10.1007/s11695-024-07257-7. Epub 2024 May 7.
3
Intravenous Arginine Administration Attenuates the Inflammatory Response and Improves Metabolic Profiles in Diet-Induced Obese Mice after Sleeve Gastrectomy.静脉注射精氨酸可减轻袖状胃切除术后饮食诱导肥胖小鼠的炎症反应并改善代谢状况。
Metabolites. 2022 Feb 7;12(2):153. doi: 10.3390/metabo12020153.
4
Comparative Effectiveness of Laparoscopic Sleeve Gastrectomy in Morbidly Obese and Super Obese Patients.腹腔镜袖状胃切除术在病态肥胖和超级肥胖患者中的比较疗效
Cureus. 2021 Dec 27;13(12):e20767. doi: 10.7759/cureus.20767. eCollection 2021 Dec.
5
Revisional Surgeries of Laparoscopic Sleeve Gastrectomy.腹腔镜袖状胃切除术的修复手术
Diabetes Metab Syndr Obes. 2021 Feb 10;14:575-588. doi: 10.2147/DMSO.S295162. eCollection 2021.
6
Intravenous Glutamine Administration Improves Glucose Tolerance and Attenuates the Inflammatory Response in Diet-Induced Obese Mice after Sleeve Gastrectomy.静脉内给予谷氨酰胺可改善袖状胃切除术后饮食诱导肥胖小鼠的葡萄糖耐量并减轻其炎症反应。
Nutrients. 2020 Oct 19;12(10):3192. doi: 10.3390/nu12103192.
7
[Not Available].[无可用内容]
Can Fam Physician. 2020 Jun;66(6):e171-e179.
8
Medication management and pharmacokinetic changes after bariatric surgery.减肥手术后的药物管理与药代动力学变化
Can Fam Physician. 2020 Jun;66(6):409-416.
9
One Anastomosis Gastric Bypass in Morbidly Obese Patients with BMI ≥ 50 kg/m: a Systematic Review Comparing It with Roux-En-Y Gastric Bypass and Sleeve Gastrectomy.肥胖症患者体重指数(BMI)≥50kg/m2 行单吻合口胃旁路术与 Roux-en-Y 胃旁路术和袖状胃切除术的对比:系统评价
Obes Surg. 2019 Sep;29(9):3039-3046. doi: 10.1007/s11695-019-04034-9.
10
Analysis of Medium-Term Weight Regain 5 Years After Laparoscopic Sleeve Gastrectomy.腹腔镜袖状胃切除术 5 年后体重中期复胖分析。
Obes Surg. 2019 Nov;29(11):3508-3513. doi: 10.1007/s11695-019-04009-w.

本文引用的文献

1
Laparoscopic sleeve gastrectomy as a stand-alone procedure for morbid obesity: report of 1,000 cases and 3-year follow-up.腹腔镜袖状胃切除术作为病态肥胖的独立治疗方法:1000 例病例报告及 3 年随访。
Obes Surg. 2012 Jun;22(6):866-71. doi: 10.1007/s11695-012-0591-6.
2
Early postoperative outcomes and medication cost savings after laparoscopic sleeve gastrectomy in morbidly obese patients with type 2 diabetes.病态肥胖的2型糖尿病患者腹腔镜袖状胃切除术后的早期手术效果及药物费用节省情况
J Obes. 2011;2011:350523. doi: 10.1155/2011/350523. Epub 2011 Dec 7.
3
Laparoscopic sleeve gastrectomy for obesity: can it be considered a definitive procedure?腹腔镜袖状胃切除术治疗肥胖症:能否将其视为一种确定性手术?
Surg Endosc. 2012 Mar;26(3):831-7. doi: 10.1007/s00464-011-1960-2. Epub 2011 Dec 17.
4
Ten-year duration of type 2 diabetes as prognostic factor for remission after sleeve gastrectomy.2 型糖尿病病史 10 年是袖状胃切除术缓解的预后因素。
Surg Obes Relat Dis. 2011 Nov-Dec;7(6):697-702. doi: 10.1016/j.soard.2011.08.014. Epub 2011 Aug 28.
5
Gastroesophageal reflux after sleeve gastrectomy in morbidly obese patients.胃食管反流病在病态肥胖患者胃袖状切除术之后。
Surg Obes Relat Dis. 2011 Nov-Dec;7(6):709-13. doi: 10.1016/j.soard.2011.08.003. Epub 2011 Aug 16.
6
Third International Summit: Current status of sleeve gastrectomy.第三届国际峰会:袖状胃切除术现状。
Surg Obes Relat Dis. 2011 Nov-Dec;7(6):749-59. doi: 10.1016/j.soard.2011.07.017. Epub 2011 Aug 10.
7
Survival among high-risk patients after bariatric surgery.高危患者在接受减重手术后的存活率。
JAMA. 2011 Jun 15;305(23):2419-26. doi: 10.1001/jama.2011.817. Epub 2011 Jun 12.
8
Association between gastroesophageal reflux disease and laparoscopic sleeve gastrectomy.胃食管反流病与腹腔镜袖状胃切除术的关系。
Surg Obes Relat Dis. 2011 Sep-Oct;7(5):569-72. doi: 10.1016/j.soard.2011.01.040. Epub 2011 Mar 22.
9
A review of laparoscopic sleeve gastrectomy for morbid obesity.腹腔镜袖状胃切除术治疗病态肥胖的综述。
Obes Surg. 2010 Aug;20(8):1171-7. doi: 10.1007/s11695-010-0145-8.
10
Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin.单纯袖状胃切除术作为确定性减重术:5 年减重和胃饥饿素结果。
Obes Surg. 2010 May;20(5):535-40. doi: 10.1007/s11695-009-0066-6. Epub 2010 Jan 22.